GLP-1s Tied to Lower Rates of MS Relapse Activity, Real-World Study Shows

(MedPage Today) -- Multiple sclerosis (MS) patients exposed to a GLP-1 receptor agonist had lower rates of relapse activity and steroid use, reduced incidence of optic neuritis, and fewer demyelinating events compared with those who didn't use...